<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>NEUROPROTECTIVE POTENTIALS OF THE ETHANOL EXTRACT OF Adenopus breviflorus (Benth) FRUIT IN SWISS MICE AND WISTAR RATS</title>
<link href="http://hdl.handle.net/123456789/2394" rel="alternate"/>
<subtitle/>
<id>http://hdl.handle.net/123456789/2394</id>
<updated>2026-04-15T14:18:15Z</updated>
<dc:date>2026-04-15T14:18:15Z</dc:date>
<entry>
<title>NEUROPROTECTIVE POTENTIALS OF THE ETHANOL EXTRACT OF Adenopus breviflorus (Benth) FRUIT IN SWISS MICE AND WISTAR RATS</title>
<link href="http://hdl.handle.net/123456789/2395" rel="alternate"/>
<author>
<name>OYEBANJO, Oyetola Tolulope</name>
</author>
<id>http://hdl.handle.net/123456789/2395</id>
<updated>2025-11-06T15:28:20Z</updated>
<published>2023-12-01T00:00:00Z</published>
<summary type="text">NEUROPROTECTIVE POTENTIALS OF THE ETHANOL EXTRACT OF Adenopus breviflorus (Benth) FRUIT IN SWISS MICE AND WISTAR RATS
OYEBANJO, Oyetola Tolulope
Neuroinflammation is a well-characterised feature of neurodegenerative diseases affecting&#13;
individuals’ movement, memory and speech. The use of synthetic drugs to improve&#13;
cognition and motor functions caused by inflammation in neurodegenerative diseases has&#13;
been associated with adverse effects. Tropical fruits offer therapeutic approaches in&#13;
mitigating inflammation peripherally and centrally. Adenopus breviflorus fruit used as&#13;
anticonvulsant and pain reliever in folkloric medicine has not been fully evaluated for its&#13;
neuroprotective activity. This study was designed to investigate the neuroprotective&#13;
potentials of ethanol extract of Adenopus breviflorus (EEAB) fruit in Swiss mice and Wistar&#13;
rats.&#13;
Ripe fruits of Adenopus breviflorus were authenticated at Forest Herbarium Ibadan (FHI:&#13;
112244), air-dried and extracted with 70% ethanol to obtain EEAB. In the anti-nociceptive&#13;
study, 30 male Swiss mice (25-30g) were divided into six groups (n=5): control (distilled&#13;
water, 10mL/kg), EEAB (25, 50, 100, 200mg/kg) and indomethacin (10mg/kg). Anti-&#13;
nociceptive activity was evaluated 1hour after by Acetic Acid-induced writhing Test&#13;
(AAT). In the inflammation study, 30 male Wistar rats (150-180g), were divided into six&#13;
groups (n=5): normal-saline (10mL/kg), carrageenan (1%, s.c.), EEAB (50, 100, 200mg/kg)&#13;
and indomethacin (5mg/kg). Air-pouch was induced in the animals for six days after which&#13;
animals in groups 3-6 were challenged with carrageenan for 24hours. Exudates from the&#13;
air-pouch were evaluated for Total Leukocyte Counts (TLC) and neutrophils using standard&#13;
techniques while Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-6 were determined&#13;
by ELISA. In the lipopolysaccharide-induced neuroinflammation model, 20 male Wistar&#13;
rats (150-200g) were divided into four groups (n=5): normal saline (10mL/kg),&#13;
lipopolysaccharide (250μg/kg, i.p.), EEAB (200mg/kg) and donepezil (0.5mg/kg i.p.).&#13;
Memory function was assessed using Y-maze Tests (YMT). The Prefrontal Cortex (PFC),&#13;
striatum and hippocampus were evaluated for inflammatory cytokines (TNF-α and&#13;
Interleukin-6), neuronal morphology using Nissl and Golgi stains, and neuronal&#13;
immunohistochemistry for expression of Amyloid-beta (Aβ) and Nuclear Factor kappa-B&#13;
(NF-κB). Data were analysed using descriptive statistics and ANOVA at α0.05.&#13;
vi&#13;
The EEAB (100, 200mg/kg) significantly reduced writhing in AAT (27.83±8.89,&#13;
22.17±3.31) compared with control (46.67±4.03). The EEAB (100, 200mg/kg) relative to&#13;
carrageenan-control significantly reduced TLC and neutrophil count. A significant&#13;
reduction in TNF-α (337.20±29.29, 174.40±29.22 vs 521.80±35.02pg/ml exudate) and&#13;
Interleukin-6 (289.90±26.48, 272.0±15.94 vs 392.10±17.69pg/ml exudate) of EEAB (100,&#13;
200mg/kg) compared with carrageenan-control was observed in the inflammation study.&#13;
The EEAB (200mg/kg) significantly increased percentage alternations (69.72±2.56) in&#13;
YMT relative to lipopolysaccharide-alone (55.63±2.82). The EEAB (200mg/kg) relative to&#13;
lipopolysaccharide-alone significantly reduced TNF-α (pg/mg protein) in striatum&#13;
(2.42±0.06 vs 3.19±0.12), and hippocampus (1.96±0.04 vs 2.32±0.10); and Interleukin-6&#13;
(pg/mg protein) in striatum (2.62±0.11 vs 3.71±0.33) alone. Neuronal morphology and&#13;
dendritic arborization were preserved by EEAB (200mg/kg). The EEAB (200 mg/kg)&#13;
relative to lipopolysaccharide-alone significantly decreased expressions of Aβ in the PFC&#13;
(5.92±0.33 vs 15.46±0.77), and hippocampus (13.51±0.53 vs 17.19±1.44); and NF-κB in&#13;
the PFC (8.61±1.03 vs 20.73±1.08), striatum (7.52±1.00 vs 18.84±0.77), and hippocampus&#13;
(1.70±1.35 vs 14.08±1.13).&#13;
Adenopus breviflorus fruit exhibited neuroprotective activities through repression of pro-&#13;
inflammatory cytokines, amyloid beta and nuclear factor kappa-B in Swiss mice and Wistar&#13;
rats.
</summary>
<dc:date>2023-12-01T00:00:00Z</dc:date>
</entry>
</feed>
